Cytomedix Insider Dean Tozer Acquires 48,000 Shares (CMXI)
Cytomedix (NASDAQ:CMXI) Insider Dean Tozer acquired 48,000 shares of the stock on the open market in a transaction dated Wednesday, August 20th. The shares were purchased at an average price of $0.39 per share, for a total transaction of $18,720.00. Following the completion of the transaction, the insider now directly owns 48,000 shares of the company’s stock, valued at approximately $18,720. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Cytomedix (NASDAQ:CMXI) traded up 2.63% during mid-day trading on Monday, hitting $0.39. 15,000 shares of the company’s stock traded hands. Cytomedix has a one year low of $0.33 and a one year high of $0.68. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.47. The company’s market cap is $48.5 million.
Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.
Receive News & Ratings for Cytomedix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytomedix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.